Agencies working with Russia to set biosimilar standards

05/20/2013 | In-PharmaTechnologist.com

The World Health Organization, national regulatory agencies and international pharmaceutical associations met in Russia to set standards for the manufacture of biologic and biosimiliar products in that country. A key focus is establishing definitions and regulations for biosimilars, which are not yet recognized as distinct products under Russian law.

View Full Article in:

In-PharmaTechnologist.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC